These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7804440)

  • 1. Exaggerated blood pressure response to angiotensin II in patients with Cushing's syndrome due to adrenocortical adenoma.
    Yasuda G; Shionoiri H; Umemura S; Takasaki I; Ishii M
    Eur J Endocrinol; 1994 Dec; 131(6):582-8. PubMed ID: 7804440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple factors contribute to the pathogenesis of hypertension in Cushing's syndrome.
    Saruta T; Suzuki H; Handa M; Igarashi Y; Kondo K; Senba S
    J Clin Endocrinol Metab; 1986 Feb; 62(2):275-9. PubMed ID: 3510223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of angiotensin I converting enzyme inhibitor (SQ 14,225) on the responses of blood pressure and steroid hormone to angiotensin II and ACTH infusion in hypertensive subjects.
    Ueda Y; Honda M; Hatano M
    Jpn Circ J; 1982 Mar; 46(3):267-73. PubMed ID: 6278173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension and aldosterone overproduction without renin suppression in Cushing's syndrome from an adrenal adenoma.
    Guthrie GP; Kotchen TA
    Am J Med; 1979 Sep; 67(3):524-8. PubMed ID: 474601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cushing's disease: evaluation of mineralocorticoid-induced hypertension.
    Yasuda G; Shionoiri H; Hayashi S; Umemura S; Ikeda Y; Ishii M
    Intern Med; 1993 Oct; 32(10):784-8. PubMed ID: 8012073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renin-angiotensin system and plasma aldosterone in Cushing's syndrome.
    Baba T; Aoyagi K; Murabayashi S; Sasaki K; Nigawara K; Takebe K
    Endocrinol Jpn; 1983 Dec; 30(6):715-21. PubMed ID: 6327249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impaired control of plasma renin activity in hypertensive patients with end-stage renal disease due to chronic glomerulonephritis.
    Yasuda G; Nagasawa T; Umemura S; Shionoiri H; Ishii M
    Clin Nephrol; 1994 Nov; 42(5):300-8. PubMed ID: 7851031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for an angiotensinogenic mechanism of the hypertension of Cushing's syndrome.
    Dalakos TG; Elias AN; Anderson GH; Streeten DH; Schroeder ET
    J Clin Endocrinol Metab; 1978 Jan; 46(1):114-8. PubMed ID: 752014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of saralasin (1sar-8-ala-angiotensin II) on blood pressure in patients with Cushing's syndrome.
    Vetter W; Vetter H; Beckerhoff R; Redlich B; Cottier P; Siegenthaler W
    Klin Wochenschr; 1976 Jul; 54(14):661-3. PubMed ID: 979066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on abnormalities of adrenal steroidogenesis in essential hypertension, primary aldosteronism and renovascular hypertension: responses of plasma steroids to angiotensin III].
    Itoh N
    Nihon Naibunpi Gakkai Zasshi; 1988 May; 64(5):419-38. PubMed ID: 3410145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of the captopril screening test for primary aldosteronism.
    Naomi S; Iwaoka T; Umeda T; Inoue J; Hamasaki S; Miura F; Fujii Y; Sato T
    Jpn Heart J; 1985 Jul; 26(4):549-56. PubMed ID: 3903249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian blood pressure variation in patients with renovascular hypertension or primary aldosteronism.
    Imai Y; Abe K; Sasaki S; Munakata M; Minami N; Sakuma H; Hashimoto J; Yabe T; Watanabe N; Sakuma M
    Clin Exp Hypertens A; 1992; 14(6):1141-67. PubMed ID: 1424221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma 18-oxocortisol levels in the patients with adrenocortical disorders.
    Yamakita N; Mune T; Morita H; Yasuda K; Miura K; Gomez-Sanchez CE
    Clin Endocrinol (Oxf); 1994 May; 40(5):583-7. PubMed ID: 8013138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
    Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML
    Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a single administration of captopril on hemodynamics and serum angiotensin converting enzyme activity, plasma renin activity and plasma aldosterone concentration in hypertensive patients.
    Hashimoto H; Hiwada K; Kokubu T
    Jpn Circ J; 1981 Feb; 45(2):176-80. PubMed ID: 6262543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of aging on the renin angiotensin system in patients with renovascular hypertension.
    Morishita R; Higaki J; Mikami H; Matsukawa N; Ogihara T
    Methods Find Exp Clin Pharmacol; 1992; 14(1):17-21. PubMed ID: 1619967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Usefulness of converting enzyme inhibitors in diagnosis of renovascular hypertension. I. Comparison of the effect of angiotensin converting enzyme inhibition on blood pressure and plasma renin activity in patients with primary hypertension and renovascular hypertension].
    Posadzy-Małaczyńska A
    Przegl Lek; 1997; 54(5):314-9. PubMed ID: 9380805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of angiotensin II and converting enzyme inhibitor (captopril) on blood pressure, plasma renin activity and aldosterone in primary aldosteronism.
    Mantero F; Fallo F; Opocher G; Armanini D; Boscaro M; Scaroni C
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():289s-293s. PubMed ID: 7032817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders.
    Yamamoto T; Doi K; Ogihara T; Ichihara K; Hata T; Kumahara Y
    Prog Biochem Pharmacol; 1976; 12():174-89. PubMed ID: 1019163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The usefulness of the captopril test as a simultaneous screening for primary aldosteronism and renovascular hypertension.
    Iwaoka T; Umeda T; Naomi S; Inoue J; Sasaki M; Yamauchi J; Sato T
    Am J Hypertens; 1993 Nov; 6(11 Pt 1):899-906. PubMed ID: 8305162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.